$HPQ
HEWLETT PACKARD CO
CIK:0000047217|SEC Filings
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jul. 31, 2026 |
Jul. 31, 2025 |
Jul. 31, 2026 |
Jul. 31, 2025 |
|
| Net revenue: | ||||
| Total net revenue | $ 15,677 | $ 13,932 | $ 44,523 | $ 40,656 |
| Cost of net revenue: | ||||
| Total cost of net revenue | 12,732 | 11,081 | 35,727 | 32,226 |
| Gross profit | 2,945 | 2,851 | 8,796 | 8,430 |
| Research and development | 389 | 406 | 1,213 | 1,204 |
| Selling, general and administrative | 1,537 | 1,452 | 4,555 | 4,391 |
| Restructuring and other charges | 48 | 110 | 539 | 302 |
| Acquisition and divestiture charges | 4 | 8 | 6 | 31 |
| Amortization of intangible assets | 75 | 159 | 220 | 287 |
| Total operating expenses | 2,053 | 2,135 | 6,533 | 6,215 |
| Earnings from operations | 892 | 716 | 2,263 | 2,215 |
| Interest and other, net | (94) | (92) | (301) | (381) |
| Earnings before taxes | 798 | 624 | 1,962 | 1,834 |
| (Provision for) benefit from taxes | (137) | 139 | (306) | (100) |
| Net earnings | $ 661 | $ 763 | $ 1,656 | $ 1,734 |
| Net earnings per share: | ||||
| Basic (usd per share) | $ 0.72 | $ 0.81 | $ 1.80 | $ 1.83 |
| Diluted (usd per share) | $ 0.71 | $ 0.80 | $ 1.79 | $ 1.82 |
| Weighted-average shares used to compute net earnings per share: | ||||
| Basic (in shares) | 919 | 947 | 922 | 948 |
| Diluted (in shares) | 927 | 954 | 927 | 955 |
| Products | ||||
| Net revenue: | ||||
| Total net revenue | $ 14,825 | $ 13,114 | $ 41,986 | $ 38,232 |
| Cost of net revenue: | ||||
| Total cost of net revenue | 12,256 | 10,599 | 34,312 | 30,800 |
| Services | ||||
| Net revenue: | ||||
| Total net revenue | 852 | 818 | 2,537 | 2,424 |
| Cost of net revenue: | ||||
| Total cost of net revenue | $ 476 | $ 482 | $ 1,415 | $ 1,426 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions |
Jul. 31, 2026 |
Oct. 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash, cash equivalents and restricted cash | $ 4,169 | $ 3,705 |
| Accounts receivable, net of allowance for credit losses of $57 and $83 as of July 31, 2026 and October 31, 2025 | 7,168 | 5,692 |
| Inventory | 10,322 | 8,512 |
| Other current assets | 5,087 | 4,544 |
| Total current assets | 26,746 | 22,453 |
| Property, plant and equipment, net | 3,110 | 3,049 |
| Goodwill | 8,726 | 8,706 |
| Other non-current assets | 7,119 | 7,561 |
| Total assets | 45,701 | 41,769 |
| Current liabilities: | ||
| Notes payable and short-term borrowings | 1,292 | 845 |
| Accounts payable | 21,383 | 18,051 |
| Other current liabilities | 11,288 | 10,362 |
| Total current liabilities | 33,963 | 29,258 |
| Long-term debt | 7,868 | 8,821 |
| Other non-current liabilities | 3,962 | 4,036 |
| Stockholders’ deficit: | ||
| Preferred stock, $0.01 par value (300 shares authorized; none issued) | 0 | 0 |
| Common stock, $0.01 par value (9,600 shares authorized; 903 and 921 shares issued and outstanding as of July 31, 2026 and October 31, 2025) | 9 | 9 |
| Additional paid-in capital | 2,364 | 2,129 |
| Accumulated deficit | (2,117) | (2,027) |
| Accumulated other comprehensive loss | (348) | (457) |
| Total stockholders’ deficit | (92) | (346) |
| Total liabilities and stockholders’ deficit | $ 45,701 | $ 41,769 |